John Pasquesi - Business-News-Today.com

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Acumen Pharmaceuticals faces strategic reset with $78.6m cash after Alzheimer’s drug failure

NRx Pharmaceuticals moves toward ketamine sales after FDA approval of domestic injectable product

Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?

Affle 3i to acquire Perion for $420m, but its $228m cash balance changes the deal maths

Editorial infographic highlighting BioConsortia’s $15 million equity funding, featuring cornfields, agricultural biotechnology laboratory equipment and a New Zealand map, alongside key points on Always N and Zaffre commercialization, reported product adoption, promising corn yield trials and global expansion challenges.

Read More

Healthcare Industry News

Can microbes cut farmers’ fertilizer bills? BioConsortia’s $15m bet is getting serious

BioConsortia has secured $15 million in fresh equity funding to accelerate commercialization of Always N and Zaffre. Stronger reported adoption in New Zealand and promising corn yield trials support expansion, but manufacturing economics, regulatory approvals and consistent field performance remain central to its global ambitions.

byPallavi Madhiraju

October 11, 2026

web analytics